Skip to main content
Top
Published in: Clinical Research in Cardiology 9/2017

Open Access 01-09-2017 | Original Paper

Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation

Authors: Mohammad Abdelghani, Rafael Cavalcante, Yosuke Miyazaki, Robbert J. de Winter, Rogério Sarmento-Leite, José A. Mangione, Alexandre Abizaid, Pedro A. Lemos, Patrick W. Serruys, Fabio S. de Brito Jr.

Published in: Clinical Research in Cardiology | Issue 9/2017

Login to get access

Abstract

Background

Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. We sought to investigate the prevalence, the predictors, and the prognostic impact of residual impairment of functional capacity after TAVI.

Methods and results

Out of 790 patients undergoing TAVI with impaired functional capacity (NYHA II–IV) at baseline, NYHA functional class improved in 592 (86.5%) and remained unchanged/worsened in 92 (13.5%) at follow-up [median (IQR): 419 (208–807) days] after TAVI. Normal functional capacity (NYHA I) was recovered in 65.5% (n = 448) of patients, while the rest had variable degrees of residual impairment. On multivariable regression analysis, atrial fibrillation [odds ratio-OR, 2.08 (1.21–3.58), p = 0.008], low-flow–low-gradient AS [OR, 1.97 (1.09–3.57), p = 0.026], chronic obstructive pulmonary disease [OR, 1.92 (1.19–3.12), p = 0.008], and lower hemoglobin at baseline [OR, 1.11 (1.01–1.21) for each g% decrement, p = 0.036] were independently associated with residual impairment of functional capacity. All-cause and cardiac mortality were significantly higher in those with residual impairment of functional capacity than in those in NYHA I class [hazard ratio-HR: 2.37 (95% CI: 1.51–3.72), p < 0.001 and 2.16 (95% CI: 1.08–4.35), p = 0.030, respectively]. Even mild residual functional impairment (NYHA II) was associated with a higher all-cause [HR: 2.02 (95% CI: 1.10–3.72), p = 0.023] and cardiac [HR: 2.08 (95% CI: 1.42–3.07), p < 0.001] mortality.

Conclusion

Residual impairment of functional capacity is common after TAVI and is independently associated with increased mortality. Predictors of residual impairment of functional status are predominantly patient-rather than procedure-related.
Appendix
Available only for authorised users
Literature
2.
go back to reference Beach JM, Mihaljevic T, Rajeswaran J, Marwick T, Edwards ST, Nowicki ER, Thomas J, Svensson LG, Griffin B, Gillinov AM et al (2014) Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 147(1):362–369 (e368) CrossRefPubMed Beach JM, Mihaljevic T, Rajeswaran J, Marwick T, Edwards ST, Nowicki ER, Thomas J, Svensson LG, Griffin B, Gillinov AM et al (2014) Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 147(1):362–369 (e368) CrossRefPubMed
3.
go back to reference Laskey WK, Kussmaul WG 3rd, Noordergraaf A (2009) Systemic arterial response to exercise in patients with aortic valve stenosis. Circulation 119(7):996–1004CrossRefPubMed Laskey WK, Kussmaul WG 3rd, Noordergraaf A (2009) Systemic arterial response to exercise in patients with aortic valve stenosis. Circulation 119(7):996–1004CrossRefPubMed
4.
go back to reference Yotti R, Bermejo J, Gutierrez-Ibanes E, Perez del Villar C, Mombiela T, Elizaga J, Benito Y, Gonzalez-Mansilla A, Barrio A, Rodriguez-Perez D et al (2015) Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement. J Am Coll Cardiol 65(5):423–433CrossRefPubMed Yotti R, Bermejo J, Gutierrez-Ibanes E, Perez del Villar C, Mombiela T, Elizaga J, Benito Y, Gonzalez-Mansilla A, Barrio A, Rodriguez-Perez D et al (2015) Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement. J Am Coll Cardiol 65(5):423–433CrossRefPubMed
5.
go back to reference Gavina C, Falcao-Pires I, Pinho P, Manso MC, Goncalves A, Rocha-Goncalves F, Leite-Moreira A (2016) Relevance of residual left ventricular hypertrophy after surgery for isolated aortic stenosis. Eur J Cardiothorac Surg 49(3):952–959CrossRefPubMed Gavina C, Falcao-Pires I, Pinho P, Manso MC, Goncalves A, Rocha-Goncalves F, Leite-Moreira A (2016) Relevance of residual left ventricular hypertrophy after surgery for isolated aortic stenosis. Eur J Cardiothorac Surg 49(3):952–959CrossRefPubMed
6.
go back to reference Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376(14):1321–1331CrossRefPubMed Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376(14):1321–1331CrossRefPubMed
7.
go back to reference Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798CrossRefPubMed Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798CrossRefPubMed
8.
go back to reference Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed
9.
go back to reference Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, Thabane L, Guyatt GH (2016) Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ 354:i5130CrossRefPubMedPubMedCentral Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, Thabane L, Guyatt GH (2016) Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ 354:i5130CrossRefPubMedPubMedCentral
10.
go back to reference Lauck SB, Baumbusch J, Achtem L, Forman JM, Carroll SL, Cheung A, Ye J, Wood DA, Webb JG (2016) Factors influencing the decision of older adults to be assessed for transcatheter aortic valve implantation: an exploratory study. Eur J Cardiovasc Nurs 15(7):486–494CrossRefPubMed Lauck SB, Baumbusch J, Achtem L, Forman JM, Carroll SL, Cheung A, Ye J, Wood DA, Webb JG (2016) Factors influencing the decision of older adults to be assessed for transcatheter aortic valve implantation: an exploratory study. Eur J Cardiovasc Nurs 15(7):486–494CrossRefPubMed
11.
go back to reference de Brito FS, LA Jr Carvalho, Sarmento-Leite R, Mangione JA, Lemos P, Siciliano A, Caramori P, Sao Thiago L, Grube E, Abizaid A (2015) Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry. Catheter Cardiovasc Interv 85(5):E153–E162CrossRefPubMed de Brito FS, LA Jr Carvalho, Sarmento-Leite R, Mangione JA, Lemos P, Siciliano A, Caramori P, Sao Thiago L, Grube E, Abizaid A (2015) Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry. Catheter Cardiovasc Interv 85(5):E153–E162CrossRefPubMed
12.
go back to reference Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42(5):S45–S60CrossRefPubMed Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42(5):S45–S60CrossRefPubMed
13.
go back to reference Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):e57–e185CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):e57–e185CrossRefPubMed
14.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847CrossRefPubMed
15.
go back to reference Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496CrossRefPubMed Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496CrossRefPubMed
16.
go back to reference Puri R, Iung B, Cohen DJ, Rodes-Cabau J (2016) TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J 37(28):2217–2225CrossRefPubMed Puri R, Iung B, Cohen DJ, Rodes-Cabau J (2016) TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J 37(28):2217–2225CrossRefPubMed
17.
go back to reference Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607CrossRefPubMed Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607CrossRefPubMed
18.
go back to reference Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620CrossRefPubMed Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620CrossRefPubMed
19.
go back to reference Alonso-Coello P, Montori VM, Diaz MG, Devereaux PJ, Mas G, Diez AI, Sola I, Roura M, Souto JC, Oliver S et al (2015) Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives. Health Expect 18(6):2318–2327CrossRefPubMed Alonso-Coello P, Montori VM, Diaz MG, Devereaux PJ, Mas G, Diez AI, Sola I, Roura M, Souto JC, Oliver S et al (2015) Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives. Health Expect 18(6):2318–2327CrossRefPubMed
20.
go back to reference Hussain AI, Garratt AM, Brunborg C, Aakhus S, Gullestad L, Pettersen KI (2016) Eliciting patient risk willingness in clinical consultations as a means of improving decision-making of aortic valve replacement. J Am Heart Assoc 5(3):e002828CrossRefPubMedPubMedCentral Hussain AI, Garratt AM, Brunborg C, Aakhus S, Gullestad L, Pettersen KI (2016) Eliciting patient risk willingness in clinical consultations as a means of improving decision-making of aortic valve replacement. J Am Heart Assoc 5(3):e002828CrossRefPubMedPubMedCentral
21.
go back to reference Lafitte S, Perlant M, Reant P, Serri K, Douard H, DeMaria A, Roudaut R (2009) Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr 10(3):414–419CrossRefPubMed Lafitte S, Perlant M, Reant P, Serri K, Douard H, DeMaria A, Roudaut R (2009) Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr 10(3):414–419CrossRefPubMed
22.
go back to reference Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD (2003) Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107(14):1884–1890CrossRefPubMed Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD (2003) Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107(14):1884–1890CrossRefPubMed
23.
go back to reference Eleid MF, Goel K, Murad MH, Erwin PJ, Suri RM, Greason KL, Nishimura RA, Rihal CS, Holmes DR Jr (2015) Meta-analysis of the prognostic impact of stroke volume, gradient, and ejection fraction after transcatheter aortic valve implantation. Am J Cardiol 116(6):989–994CrossRefPubMed Eleid MF, Goel K, Murad MH, Erwin PJ, Suri RM, Greason KL, Nishimura RA, Rihal CS, Holmes DR Jr (2015) Meta-analysis of the prognostic impact of stroke volume, gradient, and ejection fraction after transcatheter aortic valve implantation. Am J Cardiol 116(6):989–994CrossRefPubMed
24.
25.
go back to reference Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P (2005) Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 46(2):291–298CrossRefPubMed Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P (2005) Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 46(2):291–298CrossRefPubMed
26.
go back to reference Cho IJ, Chang HJ, Heo R, Kim IC, Sung JM, Chang BC, Shim CY, Hong GR, Chung N (2016) Association of thoracic aorta calcium score with left ventricular hypertrophy and clinical outcomes in patients with severe aortic stenosis after aortic valve replacement. Ann Thorac Surg Cho IJ, Chang HJ, Heo R, Kim IC, Sung JM, Chang BC, Shim CY, Hong GR, Chung N (2016) Association of thoracic aorta calcium score with left ventricular hypertrophy and clinical outcomes in patients with severe aortic stenosis after aortic valve replacement. Ann Thorac Surg
27.
go back to reference Harbaoui B, Courand PY, Charles P, Dauphin R, Boussel L, Jegaden O, Dubreuil O, de Gevigney G, Lantelme P (2015) Aortic calcifications present the next challenge after TAVR. J Am Coll Cardiol 65(10):1058–1060CrossRefPubMed Harbaoui B, Courand PY, Charles P, Dauphin R, Boussel L, Jegaden O, Dubreuil O, de Gevigney G, Lantelme P (2015) Aortic calcifications present the next challenge after TAVR. J Am Coll Cardiol 65(10):1058–1060CrossRefPubMed
28.
go back to reference Nigri M, Azevedo CF, Rochitte CE, Schraibman V, Tarasoutchi F, Pommerantzeff PM, Brandao CM, Sampaio RO, Parga JR, Avila LF et al (2009) Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology. Am Heart J 157(2):361–368CrossRefPubMed Nigri M, Azevedo CF, Rochitte CE, Schraibman V, Tarasoutchi F, Pommerantzeff PM, Brandao CM, Sampaio RO, Parga JR, Avila LF et al (2009) Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology. Am Heart J 157(2):361–368CrossRefPubMed
29.
go back to reference Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Voelker W, Ertl G et al (2009) Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120(7):577–584CrossRefPubMed Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Voelker W, Ertl G et al (2009) Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120(7):577–584CrossRefPubMed
30.
go back to reference Lange R, Beckmann A, Neumann T, Krane M, Deutsch MA, Landwehr S, Kotting J, Welz A, Zahn R, Cremer J et al (2016) Quality of Life After Transcatheter Aortic Valve Replacement: prospective Data From GARY (German Aortic Valve Registry). JACC Cardiovasc Interv 9(24):2541–2554CrossRefPubMed Lange R, Beckmann A, Neumann T, Krane M, Deutsch MA, Landwehr S, Kotting J, Welz A, Zahn R, Cremer J et al (2016) Quality of Life After Transcatheter Aortic Valve Replacement: prospective Data From GARY (German Aortic Valve Registry). JACC Cardiovasc Interv 9(24):2541–2554CrossRefPubMed
31.
go back to reference Biermann J, Horack M, Kahlert P, Schneider S, Nickenig G, Zahn R, Senges J, Erbel R, Wasem J, Neumann T (2015) The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol 104(10):877–886CrossRefPubMed Biermann J, Horack M, Kahlert P, Schneider S, Nickenig G, Zahn R, Senges J, Erbel R, Wasem J, Neumann T (2015) The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol 104(10):877–886CrossRefPubMed
Metadata
Title
Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
Authors
Mohammad Abdelghani
Rafael Cavalcante
Yosuke Miyazaki
Robbert J. de Winter
Rogério Sarmento-Leite
José A. Mangione
Alexandre Abizaid
Pedro A. Lemos
Patrick W. Serruys
Fabio S. de Brito Jr.
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 9/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1119-9

Other articles of this Issue 9/2017

Clinical Research in Cardiology 9/2017 Go to the issue